Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06208202 · ClinicalTrials.gov registry record · NA
Perceptions of E-Cigarettes and Synthetic Cooling Agents, The ICE Study
A NA study of Exposure and Abuse Tobacco, sponsored by Ohio State University Comprehensive Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 1
- Study location
NCT06208202: Recruiting NA study of Exposure and Abuse Tobacco, sponsored by Ohio State University Comprehensive Cancer Center.
NCT06208202 is a NA study of Exposure and Abuse Tobacco that is actively recruiting participants, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 300 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06208202, a NA study of Exposure and Abuse Tobacco, is actively recruiting participants, sponsored by Ohio State University Comprehensive Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates how synthetic cooling additives like WS-3 and WS-23 impact e-cigarette perceptions, use behavior, and toxicant exposure.
Primary Outcome
Satisfaction and psychological reward of e-cigarette (EC) vaping will be measured by the Modified Cigarette Evaluation Questionnaire (mCEQ). The mCEQ asks questions relating to satisfaction of using e-cigarettes on a scale from 0 (Not at all) - 6 (Extremely).
Conditions Studied
Interventions
- OTHER Survey Administration
- BEHAVIORAL Behavioral Intervention
- OTHER Biospecimen Collection
Study Locations (1)
Ohio
- Ohio State University Comprehensive Cancer Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2024-05-08 |
| Est. Completion | 2028-06 |
| Phase | NA |
What NCT06208202 shows while recruiting
NCT06208202 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).
The record links to 2 conditions, with Exposure appearing as the primary indexed condition, and to 3 interventions - of which Survey Administration is the first listed.
NCT06208202 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT06208202 about?
NCT06208202 is a clinical study titled "Perceptions of E-Cigarettes and Synthetic Cooling Agents, The ICE Study". This study evaluates how synthetic cooling additives like WS-3 and WS-23 impact e-cigarette perceptions, use behavior, and toxicant exposure.
What is the current status of trial NCT06208202?
This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2024-05-08. Estimated completion is 2028-06.
What conditions does trial NCT06208202 study?
This clinical trial studies the following conditions: Exposure, Abuse Tobacco.
What interventions are being tested in trial NCT06208202?
The interventions under investigation include: Survey Administration (OTHER), Behavioral Intervention (BEHAVIORAL), Biospecimen Collection (OTHER).
Who is sponsoring clinical trial NCT06208202?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06208202 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Exposure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06208202's enrollment target sits among peer trials
300 330th of 2000 higher than 1,630 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI